210 related articles for article (PubMed ID: 15515406)
61. 5-HT₃ antagonists under development.
Chong Y; Choo H
Expert Opin Investig Drugs; 2010 Nov; 19(11):1309-19. PubMed ID: 20950056
[TBL] [Abstract][Full Text] [Related]
62. Stability of tramadol with three 5-HT3 receptor antagonists in polyolefin bags for patient-controlled delivery systems.
Chen FC; Zhu J; Li B; Yuan FJ; Wang LH
Drug Des Devel Ther; 2016; 10():1869-75. PubMed ID: 27350741
[TBL] [Abstract][Full Text] [Related]
63. From Chemotherapy-Induced Emesis to Neuroprotection: Therapeutic Opportunities for 5-HT3 Receptor Antagonists.
Fakhfouri G; Mousavizadeh K; Mehr SE; Dehpour AR; Zirak MR; Ghia JE; Rahimian R
Mol Neurobiol; 2015 Dec; 52(3):1670-1679. PubMed ID: 25377794
[TBL] [Abstract][Full Text] [Related]
64. [5-HT3-antagonists as a substitute for metoclopramide and domperidone: a literature review].
Mouch I; Brouwers JR; van 't Riet E; Nieboer P; Otten MH; Jansman FG
Ned Tijdschr Geneeskd; 2016; 160():A9887. PubMed ID: 27677233
[TBL] [Abstract][Full Text] [Related]
65. The use of 5-HT3 receptor antagonists in various rheumatic diseases--a clue to the mechanism of action of these agents in fibromyalgia?
Stratz T; Müller W
Scand J Rheumatol Suppl; 2000; 113():66-71. PubMed ID: 11028836
[TBL] [Abstract][Full Text] [Related]
66. Trigger point injection treatment with the 5-HT3 receptor antagonist tropisetron in patients with late whiplash-associated disorder. First results of a multiple case study.
Ettlin T
Scand J Rheumatol Suppl; 2004; 119():49-50. PubMed ID: 15515414
[TBL] [Abstract][Full Text] [Related]
67. Discovery of 2-substituted benzoxazole carboxamides as 5-HT3 receptor antagonists.
Yang Z; Fairfax DJ; Maeng JH; Masih L; Usyatinsky A; Hassler C; Isaacson S; Fitzpatrick K; DeOrazio RJ; Chen J; Harding JP; Isherwood M; Dobritsa S; Christensen KL; Wierschke JD; Bliss BI; Peterson LH; Beer CM; Cioffi C; Lynch M; Rennells WM; Richards JJ; Rust T; Khmelnitsky YL; Cohen ML; Manning DD
Bioorg Med Chem Lett; 2010 Nov; 20(22):6538-41. PubMed ID: 20889341
[TBL] [Abstract][Full Text] [Related]
68. Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential.
Greenshaw AJ
Trends Pharmacol Sci; 1993 Jul; 14(7):265-70. PubMed ID: 8105596
[TBL] [Abstract][Full Text] [Related]
69. 5-HT3 receptor antagonists and migraine therapy.
Ferrari MD
J Neurol; 1991; 238 Suppl 1():S53-6. PubMed ID: 2045832
[TBL] [Abstract][Full Text] [Related]
70. The 5-HT3 receptor as a therapeutic target.
Thompson AJ; Lummis SC
Expert Opin Ther Targets; 2007 Apr; 11(4):527-40. PubMed ID: 17373882
[TBL] [Abstract][Full Text] [Related]
71. Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonists.
Seidel MF; Müller W
Expert Opin Pharmacother; 2011 Jun; 12(9):1381-91. PubMed ID: 21323622
[TBL] [Abstract][Full Text] [Related]
72. Reappraisal of the role of dolasetron in prevention and treatment of nausea and vomiting associated with surgery or chemotherapy.
Roberts SM; Bezinover DS; Janicki PK
Cancer Manag Res; 2012; 4():67-73. PubMed ID: 22427733
[TBL] [Abstract][Full Text] [Related]
73. High-resolution structures of multiple 5-HT
Basak S; Kumar A; Ramsey S; Gibbs E; Kapoor A; Filizola M; Chakrapani S
Elife; 2020 Oct; 9():. PubMed ID: 33063666
[TBL] [Abstract][Full Text] [Related]
74. Pharmacology, toxicology and human pharmacokinetics of tropisetron.
Kutz K
Ann Oncol; 1993; 4 Suppl 3():15-8. PubMed ID: 8363993
[TBL] [Abstract][Full Text] [Related]
75. Revival of 5-HT3 antagonism as treatment of IBS-D?
Barbara G
Gut; 2014 Oct; 63(10):1530-2. PubMed ID: 24465028
[No Abstract] [Full Text] [Related]
76. Do predictors exist for the therapeutic effect of 5-HT3 receptor antagonists in fibromyalgia?
Stratz T; Müller W
Scand J Rheumatol Suppl; 2000; 113():63-5. PubMed ID: 11028835
[TBL] [Abstract][Full Text] [Related]
77. First clinical study of the selective 5-HT3 antagonist, granisetron (BRL 43694), in the acute treatment of migraine headache.
Couturier EG; Hering R; Foster CA; Steiner TJ; Clifford Rose F
Headache; 1991 May; 31(5):296-7. PubMed ID: 1650335
[TBL] [Abstract][Full Text] [Related]
78. Effect of tropisetron on circulating catecholamines and other putative biochemical markers in serum of patients with fibromyalgia.
Höcherl K; Färber L; Ladenburger S; Vosshage D; Stratz T; Müller W; Grobecker H
Scand J Rheumatol Suppl; 2000; 113():46-8. PubMed ID: 11028831
[TBL] [Abstract][Full Text] [Related]
79. [5-HT3 receptor antagonists for obstetric anesthesia].
Krick C; Hennes HJ
Anaesthesist; 2001 May; 50(5):375-6. PubMed ID: 11417277
[No Abstract] [Full Text] [Related]
80. Activation and modulation of recombinantly expressed serotonin receptor type 3A by terpenes and pungent substances.
Ziemba PM; Schreiner BS; Flegel C; Herbrechter R; Stark TD; Hofmann T; Hatt H; Werner M; Gisselmann G
Biochem Biophys Res Commun; 2015 Nov; 467(4):1090-6. PubMed ID: 26456648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
